Skip to content

Saxenda cost: the list price, with insurance and without

By the glp1doses editorial team
Every number is checked against FDA labels and official price pages. How we check

The short answer

Saxenda costs $1,349.02 at Novo Nordisk's list price, which is stated without a supply period. The Saxenda savings offer closed to new enrollees on June 30, 2023. Novo Nordisk has announced Saxenda will be discontinued, with last shipments to wholesalers in late January 2027. If you have commercial coverage, your price is your plan's copay or coinsurance.

Source: List price

Key takeaways

  • Novo Nordisk's list price is $1,349.02, stated without a supply period, so we show it per package.
  • The Saxenda savings offer closed to new enrollees on June 30, 2023. Pages still advertising it are out of date.
  • If your commercial plan covers Saxenda, your price is the plan's copay or coinsurance. Ask about it by name.
  • At 3 mg daily, a carton of 5 pens covers 30 days. Pen needles are a separate purchase.
  • Saxenda is being discontinued, so ask your prescriber and your plan what comes next, well ahead of time.

Saxenda 3 mg: every way to pay, cheapest first

This table uses the 3 mg dose. Prices can differ at other doses, so use the cost calculator for yours. Swipe the table sideways to see conditions and sources.

No price is listed for Saxenda 3 mg.

Savings-card and Medicare prices apply only if you are eligible. "From" prices that telehealth providers advertise are shown only at the lowest strength.

See every price

Every verified Saxenda price

Saxenda: price by where you buy, form and dose
Where you buyForm · dosePriceConditionsSource
List priceMulti-dose single-patient-use pen, 18 mg per 3 mL pen (6 daily doses of 3 mg per pen; sold in cartons of 3 or 5 pens) · All strengths$1,349.02/fill
Conditions

Novo Nordisk states a single list price for Saxenda without naming the supply period; the price shown is per fill (one package). Novo Nordisk has announced Saxenda will be discontinued, with last shipments to wholesalers in late January 2027, and the Saxenda Savings Offer closed to new enrollees on June 30, 2023.

novocare.com
See what a year costs

What a year of Saxenda costs

First year from the label's starting dose up to 3 mg, then each year after
How you payFormFirst yearEach later yearLate-refill year

With 30-day packs, a year is 12 fills. "Late-refill year" assumes you buy every 3 mg refill after the program's refill window has closed. Work out your own numbers with the cost calculator.

Saxenda is an older daily injection, and its pricing reflects that. Its savings offer is closed to new patients, and Novo Nordisk has announced it will be discontinued. This page sets out the list price and shows you how to work out your own cost. For doses, side effects and the missed-dose rule, see the main Saxenda guide.

The Saxenda list price

The list price: $1,349.02. This figure comes from Novo Nordisk’s own page. Two things about it matter.

First, Novo Nordisk states a single list price for Saxenda without naming the supply period. We show it per package, as the source states it.

Second, list price is the price before any discounts or rebates. Novo Nordisk’s own wording is that most people do not pay list price if their health insurance covers weight-management medications, and that your out-of-pocket cost depends on your coverage.

Offers that are closed or do not apply

  • No savings offer for new patients. The Saxenda savings offer closed to new enrollees on June 30, 2023.
  • No Medicare Bridge price. Saxenda isn’t one of the products in the Medicare GLP-1 Bridge.

Saxenda is being discontinued

Novo Nordisk has announced that Saxenda will be discontinued, with last shipments to wholesalers in late January 2027. For cost planning, this changes the question. It’s less “what’s the cheapest way to stay on Saxenda” and more “what will I move to, and what will that cost”.

If you take Saxenda, raise the change with your prescriber early. A new medicine may need a new prior authorization (the plan’s approval before it pays), and plans can take weeks to decide.

How the pen supply shapes your bill

You take Saxenda daily from a multi-dose pen, so the quantity on your prescription drives the cost more than with a weekly pen.

Each pen contains 18 mg of liraglutide and can deliver doses of 0.6 mg, 1.2 mg, 1.8 mg, 2.4 mg and 3 mg. Here’s the math at the adult dosage of 3 mg daily. 18 mg divided by 3 mg is six doses, so one pen lasts six days. Pens come in cartons of 3 or 5, and at 3 mg daily a carton of 5 covers 30 days.

Four label rules can add to what you spend:

  • Needles are separate. Pen needles aren’t included with Saxenda. The pen takes disposable needles up to 8 mm long, and you use a new one for each daily injection. That’s a second, smaller purchase every month.
  • The 30-day pen limit. You throw away a pen in use after 30 days, even if medicine remains in it. During the first weeks, when doses are low, a pen can reach that limit before it’s empty.
  • Restarting after a gap. If more than 3 days pass since your last dose, the label says to restart at 0.6 mg daily and step up again. So a lapse means weeks at doses below 3 mg while you’re still paying for the medicine.
  • The 16-week checkpoint. The label says adults who haven’t lost at least 4% of their baseline (starting) body weight 16 weeks after starting should stop Saxenda. Knowing that in advance can save you from paying for months of a medicine the label says to stop.

The supply tracker counts doses left in a pen and the 30-day limit.

Saxenda cost with insurance

If your commercial plan covers Saxenda, your price is the plan’s copay or coinsurance for it. The manufacturer savings offer is closed to new patients. Call the number on your insurance card and ask:

  1. Is Saxenda on the formulary (the plan’s list of covered drugs), and on which tier?
  2. Is prior authorization required, and what are the criteria?
  3. Which weight-management medicines will the plan cover after Saxenda is discontinued?

The third question is the one that will matter most within a few months. Some plans exclude weight-management medicines as a category. If yours does, no brand in that category will be covered without an exception.

Saxenda cost without insurance

If you pay cash, ask pharmacies directly. Request the cash price for the exact quantity on your prescription (for example, a carton of 5 pens), and note the date. Then compare it with the manufacturers’ self-pay prices for other medicines approved for weight reduction:

  • The Wegovy pen is $349 a month at 2.4 mg through NovoCare Pharmacy.
  • The Wegovy tablet is $299 a month at 25 mg.
  • Zepbound’s self-pay prices are on the Zepbound cost page.

These are different medicines with different labels, doses and side effects, and the choice between them is a clinical one for your prescriber. The comparison gives you sourced numbers to take into that conversation. The Wegovy cost page, the cost calculator and the cheapest path tool all draw on the same prices. Our guide to paying without insurance explains how the manufacturer self-pay programs work.

Saxenda and Medicare

Medicare Part D generally won’t pay for Saxenda. The Part D statute excludes agents when used for weight loss, and CMS, the federal Medicare agency, says Medicare and Medicaid generally do not cover GLP-1 drugs for the weight loss indication. Every approved use of Saxenda is weight reduction, so there’s no separately covered indication to prescribe it under.

The Medicare GLP-1 Bridge doesn’t change that for Saxenda, because Saxenda isn’t on its product list. The Bridge covers Foundayo, Wegovy and the Zepbound KwikPen for eligible Part D patients at a $50 copay per one-month supply. If you have Medicare and you take or are considering Saxenda, the Bridge guide and the eligibility checker show whether one of those medicines could be open to you.

Traps to avoid

  • Unsourced monthly prices. Novo Nordisk doesn’t attach a supply period to its Saxenda list price. A site that quotes a confident monthly cash figure with no source and no date is estimating.
  • Old savings card pages. The offer closed to new enrollees on June 30, 2023. Pages that still advertise it are out of date.
  • Stocking up without a plan. With a discontinuation announced, buying ahead may look sensible, but pens in use expire after 30 days and the 16-week checkpoint may apply to you. Talk to your prescriber first.
  • Sellers of unapproved liraglutide products. A low price from a source that isn’t a licensed pharmacy dispensing the FDA-approved product isn’t a Saxenda price.

When your insurance says no

Ask for the denial reason and the plan’s criteria in writing. If the denial is a category exclusion, an appeal for Saxenda specifically is unlikely to succeed. The more useful question is whether any weight-management medicine is covered, or whether another approved use applies to you. If it’s a prior authorization denial, your prescriber can resubmit with your BMI, weight-related conditions and history. The appeal letter generator drafts the request. The main cost guide compares what each route costs across the medicines on this site.

Where these Saxenda prices come from

We take each price from the manufacturer’s or the government’s own page, in that page’s exact wording. The method is on how we verify prices.

Frequently asked questions

How much is Saxenda without insurance?

The published figure is Novo Nordisk's list price of $1,349.02, which the company states without naming the supply period. A pharmacy's cash price can differ from list price, so ask your pharmacy for its price for your prescribed quantity and write down the date you were told.

Is there a Saxenda savings card?

Not for new patients. Novo Nordisk's Saxenda savings offer closed to new enrollees on June 30, 2023. Pages that still advertise it are out of date. If your commercial plan covers Saxenda, your price is the plan's copay or coinsurance for it.

How many Saxenda pens do I need for a month?

Each pen contains 18 mg of liraglutide, which is six daily doses at the 3 mg adult dosage, and pens come in cartons of 3 or 5. At 3 mg daily, a carton of 5 pens covers 30 days. During the first four weeks the doses are lower, so the same pens last longer.

Is Saxenda cheaper than Wegovy?

Novo Nordisk states a list price of $1,349.02 for Saxenda and $1,349.02 per package for Wegovy. Wegovy also has self-pay prices through NovoCare Pharmacy: $349 a month for the 2.4 mg pen and $299 a month for the 25 mg tablet.

Sources (11)

  1. 1.
    FDA label (DailyMed): Saxenda prescribing information, Instructions for Use
    “It contains 18 mg of liraglutide, and you can select doses of 0.6 mg, 1.2 mg, 1.8 mg, 2.4 mg and 3 mg.”
  2. 2.
    FDA label (DailyMed): Saxenda prescribing information, Instructions for Use
    “Your pen is made to be used with disposable needles up to a length of 8 mm. Pen needles are not included with your Saxenda pen.”
  3. 3.
    FDA label (DailyMed): Saxenda prescribing information, Instructions for Use
    “The Saxenda pen you are using should be thrown away after 30 days, even if it still has Saxenda left in it.”
  4. 4.
    FDA label (DailyMed): Saxenda prescribing information, section 2.1
    “If more than 3 days have elapsed since the last SAXENDA dosage, reinitiate SAXENDA at 0.6 mg daily and follow the dosage escalation schedule in Table 1, to reduce the risk of gastrointestinal adverse reactions associated with reinitiation of treatment.”
  5. 5.
    FDA label (DailyMed): Saxenda prescribing information, section 2.2
    “Evaluate the change in body weight 16 weeks after initiating SAXENDA and discontinue SAXENDA if the patient has not lost at least 4% of baseline body weight, since it is unlikely that the patient will achieve and sustain clinically meaningful weight loss with continued treatment.”
  6. 6.
    CMS: BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) Model
    “GLP-1 drugs for weight loss, along with lifestyle interventions, can help people improve their overall health, but GLP-1s are expensive and currently Medicare and Medicaid generally do not cover these drugs for the weight loss indication.”
  7. 7.
    Federal Register: Medicare and Medicaid Programs; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (proposed rule, 89 FR 99340)
    “The statutory definition of a covered Part D drug at section 1860D-2(e)(2) of the Social Security Act (the Act) excludes certain drugs and uses—specifically, those that may be excluded by Medicaid under section 1927(d)(2) of the Act. This includes, at section 1927(d)(2)(A) of the Act, “agents when used for anorexia, weight loss, or weight gain.” Historically, drugs used for weight loss have been excluded from the definition of covered Part D drug, regardless of their use for treatment of individuals with obesity, and have been an optional drug benefit for Medicaid programs.”
  8. 8.
  9. 9.
  10. 10.
  11. 11.